Preclinical Validation of a Novel Drug Lead to Treat Tuberculosis (2018–2023)

Grant type:
United States Congressionally Directed Medical Research Programs - Peer Reviewed Medical Research Program
Researchers:
  • Professor
    Frazer Institute
    Faculty of Medicine
    Professor
    Frazer Institute
    Faculty of Medicine
    Affiliate Associate Professor
    Institute for Molecular Bioscience
  • Professorial Research Fellow - GL
    Institute for Molecular Bioscience
    Professorial Research Fellow - GL
    Institute for Molecular Bioscience
    Affiliate of ARC COE for Innovation
    ARC Centre of Excellence for Innovations in Peptide and Protein Science
    Institute for Molecular Bioscience
    Affiliate Professorial Res Fellow
    School of Chemistry and Molecular Biosciences
    Faculty of Science
  • NHMRC Leadership Fellow and Group L
    Institute for Molecular Bioscience
    NHMRC Leadership Fellow and Group L
    Institute for Molecular Bioscience
    Affiliate of ARC COE for Innovation
    ARC Centre of Excellence for Innovations in Peptide and Protein Science
    Institute for Molecular Bioscience
    of Institute for Molecular Bioscien
    Institute for Molecular Bioscience
Funded by:
United States Department of Defense